Cargando…

Comparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cycles

OBJECTIVE: The aim of this study was to compare the effect of corifollitropin alfa (CFA) and recombinant follicle-stimulating hormone (rFSH) in poor-responder patients undergoing antagonist cycles. MATERIALS AND METHODS: The study was a retrospective analysis of the treatment results of 214 poor res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akarsu, Süleyman, Demir, Sibel, Gode, Funda, Işık, Ahmet Zeki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Clinical Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780561/ https://www.ncbi.nlm.nih.gov/pubmed/29379660 http://dx.doi.org/10.4274/tjod.08634

Ejemplares similares

Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients
por: Selman, Helmy, et al.
Publicado: (2016)

Corifollitropin alfa for poor responders patients, a prospective randomized study
por: Fusi, F. M., et al.
Publicado: (2020)

Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis
por: Fensore, Stefania, et al.
Publicado: (2015)

A Patient Friendly Corifollitropin Alfa Protocol without Routine Pituitary Suppression in Normal Responders
por: Wang, Huai-Ling, et al.
Publicado: (2016)

Efficacy of corifollitropin alfa followed by recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist protocol for Korean women undergoing assisted reproduction
por: Park, Hyo Young, et al.
Publicado: (2015)

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders
por: Errázuriz, Joaquín, et al.
Publicado: (2019)

Evaluation of results obtained with corifollitropin alfa after poor ovarian response in previous cycle using recombinant follicular stimulating hormone in the long-term protocol
por: Salgueiro, Lister L., et al.
Publicado: (2016)

Corifollitropin Alfa for Controlled Ovarian Stimulation in Assisted Reproductive Technologies: State of the Art
por: Carvalho, Bruno Ramalho de
Publicado: (2023)

The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
por: Seyhan, Ayse, et al.
Publicado: (2011)

The use of in vitro maturation in stimulated antagonist in vitro fertilization cycles of normo-hyperresponder women due to arrested follicular development: A rescue procedure
por: Hatırnaz, Şafak, et al.
Publicado: (2018)

Recombinant follitropin alfa/lutropin alfa in fertility treatment
por: Gibreel, Ahmed, et al.
Publicado: (2010)

Validating the Use of Corifollitropin Alfa in Progestin-Primed Ovarian Stimulation Protocol on Normal and High Responders by Comparing with Conventional Antagonist Protocol: A Retrospective Study
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity
por: Norman, Robert J., et al.
Publicado: (2011)

Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)

Corifollitropin α followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of a multicentre randomised trial
por: Polyzos, Nikolaos P, et al.
Publicado: (2013)

Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study
por: Barrenetxea, Gorka, et al.
Publicado: (2018)

Association of progesterone production with serum anti-Müllerian hormone levels in assisted reproductive technology cycles with corifollitropin alfa
por: Lee, Tsung-Hsien, et al.
Publicado: (2018)

Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016)

Corifollitropin alpha, clomiphene citrate and dydrogesterone without daily gonadotrophin: a new option of a friendly protocol for high-responder oocyte donors
por: de Melo, Anderson Sanches, et al.
Publicado: (2022)

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial
por: Leader, Arthur, et al.
Publicado: (2013)

An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism
por: Nieschlag, Eberhard, et al.
Publicado: (2017)

Corifollitropin alfa versus follitropin beta: an economic analysis alongside a randomized controlled trial in women undergoing IVF/ICSI
por: Khoa, Le Dang, et al.
Publicado: (2020)

Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35–42 years with a body weight ≥50 kg: a randomized controlled trial
por: Vuong, N L, et al.
Publicado: (2017)

Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
por: Oehninger, Sergio, et al.
Publicado: (2015)

Evaluation of the safety and efficacy of corifollitropin alfa combined with GnRH agonist triggering in oocyte donation cycles. A prospective longitudinal study
por: Tsakiridis, Ioannis, et al.
Publicado: (2020)

A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol
por: Devroey, P., et al.
Publicado: (2009)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Conventional ovarian stimulation vs. delayed single dose corifollitropin alfa ovarian stimulation in oocyte donors: a prospective randomized study. Tail trial
por: Alvarado Franco, Carlos Alberto, et al.
Publicado: (2023)

Corifolitropin-Alfa plus Five Days Letrozole Versus Daily Recombinant-FSH in Expected Normo-Responder Patients: A Retrospective Comparative Study
por: D’Amato, Giuseppe, et al.
Publicado: (2023)

A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study
por: Decleer, W., et al.
Publicado: (2014)

Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol
por: Huang, Ting-Chi, et al.
Publicado: (2021)

Corifollitropin- [Formula: see text] compared to daily r-FSH in for patients undergoing intracytoplasmic sperm injection: Clinical trial study
por: Zahiri Sorouri, Ziba, et al.
Publicado: (2019)

Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization
por: Kwee, Janet, et al.
Publicado: (2007)

Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders
por: Chen, Qiuju, et al.
Publicado: (2017)

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
por: Yang, Chunxia, et al.
Publicado: (2022)

Weaned Sows with Small Ovarian Follicles Respond Poorly to the GnRH Agonist Buserelin
por: Lopes, Tania P., et al.
Publicado: (2020)

Poor responders in in vitro fertilization (IVF) therapy: the challenge continues
por: Oehninger, S.
Publicado: (2011)

Perifollicular Vascularity in Poor Ovarian Responders in In vitro Fertilization Cycles
por: Majeed, Asifa, et al.
Publicado: (2018)

Decreased fertility in poor responder women is not related to oocyte morphological status
por: Nichi, Marcílio, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_81gcv5u61ucncaosspe71nr7fu